Skip to content

The effect of ciprofol on vasopressor requirements in patients with septic shock

The effect of ciprofol on vasopressor requirements in patients with septic shock

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097972
Enrollment
Unknown
Registered
2025-02-28
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis shock

Interventions

Cyclopofol group:A loading dose of 0.1 mg/kg of intravenous propofol was given intravenously over 4 minutes +/-30 s, followed immediately by an initial dose of 0.3 mg/kg/hour, and the dosing rate was
Propofol group:A loading dose of 0.5 mg/kg of propofol was given as an intravenous infusion over 4 minutes +/-30 s, followed immediately by an initial dose of 1.5 mg/kg/hour, and the dosing rate was a

Sponsors

Department of Intensive Care Medicine, Ningbo Medical Center LiHuiLi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>=18 years; 2. Patients with septic shock who require invasive mechanical ventilation; 3. Expected need for long-term sedation (>=24 hours); 4. The target Richmond agitation-sedation scale (RASS) of the patient's required sedation is +1 to -2 points; 5. Patients or their family members sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Known or suspected allergy to cyclopofol or propofol and their antidotes; 2. The patient has been sedated in the ICU or general ward for more than 3 days before signing the informed consent form; 3. Pregnant or lactating; 4. Other conditions judged by the investigator that the patient is not suitable for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Norepinephrine requirements in the first 24h after randomization;

Secondary

MeasureTime frame
Norepinephrine requirements in the 0, 12, 48, 72, 96h after randomization;Cumulative dose of norepinephrine;Duration of use of norepinephrine;Success rate of sedation;Duration of invasive mechanical ventilation;Hospital mortality;Length of ICU stay;Total length of stay;Total hospital costs;

Countries

China

Contacts

Public ContactDong Zhouzhou

Ningbo Medical Center LiHuiLi Hospital

lhldongzhouzhou@nbu.edu.cn+86 138 5828 7868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026